TRIAL DETAIL

Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic or Unresectable Sarcoma

Drug:
Trial Name:
Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic or Unresectable Sarcoma
NCT#:
Conditions:
Gastrointestinal Stromal Tumor
Status:
Suspended
Phase:
2
Start Date 07/01/2015
Age of Trial (yrs) 7
Treatment Phase:
Gleevec-resistant
Drug Category:
PD-1 inhibitor + CTLA-4 inhibitor
Strategy:
Immunotherapy
Trial Type:
Specifically GIST plus other cancers
Other Protocol IDs:
NCI-2015-00260, NCI-2015-00260, A091401, A091401, U10CA180821
Sponsor:
National Cancer Institute
Patient Contact:
Principal Investigator: Sandra P. D'Angelo Memorial Sloan-Kettering 212-639-7202
Contact email:
Contact Phone:
Randomized:
Randomized
IV or Oral:
Intravenous
Trial Notes:
There are over 500 sites listed as open across the US. Only major GIST centers are listed here. Check the Clinicaltrials.gov database for all potential sites and site contact information (621 listed across US).

Trial Links

Trial Results

Drug Information

Trial Sites

Name
Address
City
State
Zip
Country
660 S. Euclid Ave
St. Louis
MO
63110
USA
2650 Ridge Avenue
Evanston
IL
60201
USA
1275 York Ave
New York
NY
10065
USA
450 Brookline Ave
Boston
MA
02215-5450
USA
New York
NY
10032
USA
1475 Northwest 12th Ave
Miami
FL
33136
USA